| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/16/2009 | WO2006029084A3 Bone marrow derived oct3/4+ stem cells |
| 04/16/2009 | WO2006017184A3 HYBRID PROTEINS WITH ErbB4 EXTRACELLULAR DOMAIN AND NEUREGULIN HEPARIN-BINDING DOMAIN FOR TARGETING |
| 04/16/2009 | WO2006012359A3 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/16/2009 | WO2006007514A3 Methods for producing functional antigen presenting dentritic cells using biodegradable microparticles for delivery of antigenic materials |
| 04/16/2009 | WO2006007432A3 Nucleic acid molecules encoding wrinkled1-like polypeptides and methods of use in plants |
| 04/16/2009 | WO2005118787A3 Method of screening candidate compounds for susceptibility to biliary excretion |
| 04/16/2009 | WO2005115477A3 Non-natural ribonuclease conjugates as cytotoxic agents |
| 04/16/2009 | WO2005094279A3 Immortalized human tuberous sclerosis null angiomyolipoma cell and method of use thereof |
| 04/16/2009 | WO2005081699A3 Biomimetic organic/inorganic composites, processes for their production, and methods of use |
| 04/16/2009 | WO2005056761A3 REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi |
| 04/16/2009 | WO2005042727A3 Methods of organ regeneration |
| 04/16/2009 | US20090100551 Plant Seed Specific Promoters |
| 04/16/2009 | US20090100550 Artificial Plant Minichromosomes |
| 04/16/2009 | US20090100549 Plant galactinol synthase homologs |
| 04/16/2009 | US20090100545 Means and Methods to Modulate Flavonoid Biosynthesis in Plants and Plant Cells |
| 04/16/2009 | US20090100544 Drought Tolerant Corn with Reduced Mycotoxin |
| 04/16/2009 | US20090100543 Axmi-018, axmi-020, and axmi-021, a family of delta-endotoxin genes and methods for their use |
| 04/16/2009 | US20090100542 Promoter for epidermis-specific, pathogen-inducible transgenic expression in plants |
| 04/16/2009 | US20090100541 Transcription Factor Stress-Related Proteins and Methods of Use in Plants |
| 04/16/2009 | US20090100540 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants |
| 04/16/2009 | US20090100536 Transgenic plants with enhanced agronomic traits |
| 04/16/2009 | US20090100535 nucleic acids encoding a chimeric protein comprising a cleavage domain and a composite nucleic acid-binding region, that comprises at least two component polypeptide portions which are individually capable of binding specific nucleotide sequences |
| 04/16/2009 | US20090099341 Heparanase specific molecular probes and their use in research and medical applications |
| 04/16/2009 | US20090099338 Novel Protein Highly Producing Recombinant Animal Cell, Method for Preparing the Same, and Method for Mass-Producing Protein Using the Same |
| 04/16/2009 | US20090099336 using the conjugates in the inhibition of cell growth; cancer; monoclonal antibody or epitope-binding fragment thereof, that recognizes and binds the CA6 glycotope |
| 04/16/2009 | US20090099242 Heterocyclic inhibitors of necroptosis |
| 04/16/2009 | US20090099239 Antiviral Compounds and Methods |
| 04/16/2009 | US20090099205 Chemokine receptor binding compounds |
| 04/16/2009 | US20090099193 Eml4-alk fusion gene |
| 04/16/2009 | US20090099186 Inhibitors of viral replication |
| 04/16/2009 | US20090099183 Pyrimidines and uses thereof |
| 04/16/2009 | US20090099171 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 04/16/2009 | US20090099134 Treatment of dna damage related disorders |
| 04/16/2009 | US20090099125 Pan cancer oncolytic vectors and methods of use thereof |
| 04/16/2009 | US20090099124 Short interfering rna as an antiviral agent for hepatitis c |
| 04/16/2009 | US20090099122 USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE EPITHELIAL CELL GROWTH |
| 04/16/2009 | US20090099109 inhibition of p53 transcription by interfering with the activity of a p53 promoter using inhibitory double-stranded RNAs; use of these inhibitory RNAs in the treatment of cancers |
| 04/16/2009 | US20090099107 Methods and Compositions for Inhibition of Nuclear Factor kappaB |
| 04/16/2009 | US20090099105 Content dependent inhibitors of cytidine deaminases and uses thereof |
| 04/16/2009 | US20090099096 HIV proteases as therapeutic agents for inhibition and treatment of HIV infection in humans, administered in combination with other classes of HIV therapeutic agents, especially inhibitors of HIV reverse transcriptase |
| 04/16/2009 | US20090099087 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 04/16/2009 | US20090099081 Synthetic axmi-004 delta-endotoxin genes and methods for their use |
| 04/16/2009 | US20090099079 Novel Fungal Enzymes |
| 04/16/2009 | US20090099073 Albumin Fusion Proteins |
| 04/16/2009 | US20090099071 Sugar chain-containing albumin, production method thereof and use thereof |
| 04/16/2009 | US20090099069 Modulators of alpha-synuclein toxicity |
| 04/16/2009 | US20090099062 Pyrvinium For The Treatment of Cancer |
| 04/16/2009 | US20090099060 Modulation of line-1 reverse transcriptase |
| 04/16/2009 | US20090099038 Cell line, system and method for optical-based screening of ion-channel modulators |
| 04/16/2009 | US20090099031 Genetic package and uses thereof |
| 04/16/2009 | US20090098653 Transgenomic Mitochondria, Transmitochondrial Cells and Organisms, and Methods of Making and Using |
| 04/16/2009 | US20090098651 Cardiomyocyte culture support |
| 04/16/2009 | US20090098650 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 04/16/2009 | US20090098649 Newly established cell lines from maruca vitrata |
| 04/16/2009 | US20090098648 High-titer retroviral packaging cells |
| 04/16/2009 | US20090098634 Scleroprotein of an adeno associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/16/2009 | US20090098631 Novel glutamic acid decarboxylase (GAD) proteins and methods of use |
| 04/16/2009 | US20090098630 Fusion protein, gene related to fusion protein, vector, transformants, and anti-inflammatory medicinal composition |
| 04/16/2009 | US20090098629 Comprises urogenital system specific protein for diagnosing and treating tumors; antiproliferative agents; genetic vaccine; 22P4F11 transcript and/or protein represent a useful diagnostic marker and/or therapeutic target for prostate cancer |
| 04/16/2009 | US20090098628 Methods and Devices for Microencapsulation of Cells |
| 04/16/2009 | US20090098626 Nucleic acids encoding modified cytochrome p450 enzymes and methods of use thereof |
| 04/16/2009 | US20090098622 Schizochytrium pks genes |
| 04/16/2009 | US20090098615 Genetically modified cells and methods for converting (r)-methylmalonyl coa to (s)-methylmalonyl coa |
| 04/16/2009 | US20090098614 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA |
| 04/16/2009 | US20090098611 Self-cleaving affinity tags and methods of use |
| 04/16/2009 | US20090098609 Il-2 fusion proteins with modulated selectivity |
| 04/16/2009 | US20090098604 host cells; tumor antigens; for treatment, prevention of cancer |
| 04/16/2009 | US20090098603 Polypeptides sharing sequence identity with a fibroblast growth factor polypeptide and nucleic acids encoding the same |
| 04/16/2009 | US20090098601 Selection of Host Cells Expressing Protein at High Levels |
| 04/16/2009 | US20090098593 Laboratory plate thermal vault |
| 04/16/2009 | US20090098591 Method of Correlating Marker Molecule Concentration To A Specific Cell Potency Level in Chondrocyte Culture |
| 04/16/2009 | US20090098583 Methods of detecting early renal disease in animals |
| 04/16/2009 | US20090098580 Mammalian sweet taste receptors |
| 04/16/2009 | US20090098579 Using g-protein coupled receptor as tools in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners; modulating taste perception |
| 04/16/2009 | US20090098576 Feline Pancreatic Lipase |
| 04/16/2009 | US20090098573 for use in designing and/or identifying modulators of insect behavior; biolgical pest control |
| 04/16/2009 | US20090098572 detecting a rhesus monkey BCRP polypeptide in a sample; used as a hematopoietic stem cell marker |
| 04/16/2009 | US20090098570 Lxr ligand testing method |
| 04/16/2009 | US20090098569 Novel PGC-1 Isoforms and Uses Therefor |
| 04/16/2009 | US20090098544 Marker molecules associated with lung tumors |
| 04/16/2009 | US20090098530 Cell Line For Producing Coronaviruses |
| 04/16/2009 | US20090098528 Method for determining early HCV seroconversion |
| 04/16/2009 | US20090098204 Tissue implants and methods for making and using same |
| 04/16/2009 | US20090098183 Microsphere-based materials with predefined 3d spatial and temporal control of biomaterials, porosity and/or bioactive signals |
| 04/16/2009 | US20090098177 Methods and devices for tissue repair |
| 04/16/2009 | US20090098174 Heparin coating of biological tissue |
| 04/16/2009 | US20090098159 Cultured feline fetal tissue generated in absence of mammalian polypeptides for use as bioreactor in production of inexpensive feline vaccine |
| 04/16/2009 | US20090098153 Activation of HCV-specific T cells |
| 04/16/2009 | US20090098150 Anti-acetylated huntingtin antibodies and uses therof |
| 04/16/2009 | US20090098140 Monoclonal antibodies and their use |
| 04/16/2009 | US20090098132 Composition and method for treating lupus nephritis |
| 04/16/2009 | US20090098131 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098129 Member of the TNF Ligand Family |
| 04/16/2009 | US20090098128 NPC1L1 orthologues |
| 04/16/2009 | US20090098125 PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 04/16/2009 | US20090098122 sRAGE Mimetibody, Compositions, Methods and Uses |
| 04/16/2009 | US20090098121 Monoclonal antibody fusion comprising bactericidal agent for use in targeted destruction of microorganisms; for use in health care, veterinary medicine and food processing |
| 04/16/2009 | US20090098119 Antidotes for factor xa inhibitors and methods of using the same |
| 04/16/2009 | US20090098117 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 04/16/2009 | US20090098115 Cell lines and animal models of HER2 expressing tumors |